HOME >> BIOLOGY >> NEWS
UCSF begins distributing the first of its two embryonic stem cell lines

cell biology research," says Regis B. Kelly, PhD, UCSF executive vice chancellor, office of research. "The best way to determine the therapeutic potential of embryonic stem cells is to foster research efforts in many laboratories, and the role of University labs in this effort is critical, as there is less need to focus on financial implications."

"We are very pleased to be able to share these cells with other academic researchers. The effort that has gone in to getting these cells ready for distribution has been worthwhile. Studying the basic biology of embryonic stem cells is a key step in exploring their therapeutic potential," says Meri Firpo, PhD, UCSF assistant research geneticist in the Department of Obstetrics, Gynecology and Reproductive Sciences.

Firpo led the team that derived the two cell lines in the UCSF laboratory of Roger Pedersen, PhD, at that time UCSF professor and research director, reproductive genetics unit, Department of Obstetrics, Gynecology and Reproductive Sciences, and now at the University of Cambridge, in England.

Firpo and her colleagues derived the two lines of embryonic stem cells in the winter and spring of 2001. The cells were obtained from three to five day old embryos that had been left over following fertility treatments and had been donated for research. The cells were then developed into cell "lines," large quantities of genetically identical cells created by replication initiated with a single cell in the laboratory dish.

Last fall and winter, following the establishment of the NIH Human Embryonic Stem Cell Registry, the University of California Office of the President and UCSF negotiated mutually agreeable terms with several institutions for sharing the cells with academic researchers. The negotiations took place with Geron, which funded the research and holds the exclusive commercial license to the two stem cell lines; WiCell Research Institute, a nonprofit subsidiary of Wisconsin Alumni Res
'"/>

Contact: Jennifer OBrien
jobrien@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
18-Sep-2002


Page: 1 2 3 4 5

Related biology news :

1. New hydrothermal vents discovered as South Pacific Odyssey research begins
2. DCI donor services begins distribution of tissue implants
3. Landmark, pivotal Phase IIb/III trial of biotoxin for cancer pain begins
4. Work begins on powering a sustainable future for the UK
5. As autumn approaches, this chickadees brain begins to expand
6. New study begins to unravel fate of toxic pollutants harbored in Arctic waters
7. Acorda Therapeutics begins Phase 3 trials of Fampridine-SR for chronic spinal cord injury
8. Nabi Biopharmaceuticals begins human testing of novel vaccine to fight nicotine addiction
9. The pathway to anxiety begins early in life
10. DOE begins international effort to sequence tree genome
11. Montana State University begins major trout and salmonid book collection

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/20/2016)... Jan. 20, 2016  Synaptics Incorporated (NASDAQ: ... solutions, today announced sampling of S1423, its newest ... and small screen applications including smartwatches, fitness trackers, ... round and rectangular shapes, as well as thick ... with moisture on screen, while wearing gloves, and ...
(Date:1/11/2016)... SAN JOSE, Calif. , Jan. 11, 2016 /PRNewswire/ ... developer of human interface solutions, today announced that its ... display driver integration (TDDI) products won two separate categories ... including Best Mobile Innovator and Best Technology Breakthrough. The ... overall system cost, a simplified supply chain, thinner devices, ...
(Date:1/7/2016)... Various factors have contributed to the ... biologics and biosimilars. Some of these factors include ... demand for cost-effective alternatives, growing burden of chronic ... versions of their corresponding patented biologic drugs, and ... and efficacy. The global biosimilars market is estimated ...
Breaking Biology News(10 mins):
(Date:2/6/2016)... ... February 06, 2016 , ... Contact:, Abby Mitchell, ... Excellence in Education Sponsors Teacher Training Program , Bite of Science Dinner Event ... Center for Excellence in Education (CEE) will sponsor a Bite of Science professional ...
(Date:2/5/2016)... 2016 Australian-US drug discovery and development company, Novogen ... of a new Chairman, Mr John O,Connor , and ... James Garner , has also been formally ... Acting CEO, Mr Iain Ross , will resume his ... James Garner , has also been formally appointed to ...
(Date:2/4/2016)... VA (PRWEB) , ... February ... ... cybersecurity conference presented by Bloomsburg University’s Digital Forensics Club, takes place February ... The two-day event features 20+ speakers and activities such as workshops and ...
(Date:2/4/2016)... ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), ... of targeted antiviral therapies, announced today that it will ... be held February 8-9, 2016, at the Waldorf Astoria ... & Healthcare Conference, taking place in New ... James Sapirstein , Chief Executive Officer of ContraVir, will ...
Breaking Biology Technology:
Cached News: